MHRA

The Medicines and Health products Regulatory Agency (MHRA) has issued a class second medicines recall for Clexane 4,000 IU (40mg) /0.4ml syringes  of Pharmaram Ltd.

Pharmaram has informed the MHRA that the batch of Clexane 4,000IU (40mg)/0.4ml syringes has an error on the labelling affixed to the plastic blister packaging encasing the syringe.

Product details

Batch Number Expiry Date Pack Size  First Distributed
CCL67G/D3 31/10/2022 10 syringes per pack 16/07/2020

The label incorrectly states “Clexane 6,000IU (60mg)/0.6ml Syringes”, when it should have stated “Clexane 4,000IU (40mg)/0.4ml Syringes”.

The outer carton states the correct strength; the batch number and expiry dates are also correct and match the details on the labelling.

Healthcare professionals have been adviced to stop supplying the products immediately and remove from the shelves within their pharmacies.

Patients who have been supplied this batch of Clexane 4,000IU (40mg)/0.4ml Syringes should be informed that the error is only with the labelling on the plastic blister packaging encasing the syringe.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY